Results
1
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1 companies
Formycon
Market Cap: €405.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.95
7D
-1.5%
1Y
-54.8%